GlassScriptPhysician profile
Robert A Hollis
NPI 1356393078
$1,611.88
in general payments reported to CMS, 2019-2025
20 companies · $19.40 in 2025
The $19.40 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $171 · 2021: $53.62 · 2022: $496 · 2023: $20.27 · 2024: $77.43 · 2025: $19.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.82 | 2019-2025 | |
| Intuitive Surgical, INC. | $204.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.49 | 2019-2020 | |
| Gilead Sciences, INC. | $181.09 | 2019-2022 | |
| Prescient Surgical | $133.76 | 2019 | |
| Braintree Laboratories, INC. | $106.64 | 2019 | |
| Pfizer INC. | $100.01 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.76 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $35.44 | 2023-2024 | |
| Qol Medical, LLC | $34.03 | 2019-2020 | |
| Ethicon US, LLC | $32.90 | 2019-2020 | |
| Covidien LP | $29.90 | 2019 | |
| Janssen Biotech, INC. | $27.46 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $27.00 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $26.76 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $26.75 | 2019 | |
| Boston Scientific Corporation | $23.37 | 2021 | |
| Genzyme Corporation | $22.37 | 2022 | |
| Celgene Corporation | $18.33 | 2021 | |
| Shire North American Group INC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hollis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.